EUVIMEDEUVIMED entdecken
Crossref

A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis

Wen Su, Wei Qiu, Shu-Jin Li, Shuo Wang, Jun Xie, Qi-Chao Yang, Jiming Xu, Junjie Zhang, Zhigang Xu iD, Zhi-Jun Sun iD

Advanced Materials · 2023-03 · 35 (11)

DOI: 10.1002/adma.202209379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 03.02.2023. Verfasst von Wen Su und 9 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, Schoo…. Hauptthemen laut MEDLINE: Oncolytic Viruses, Oncolytic Virotherapy, Neoplasms. Die Arbeit wurde bisher 111-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Hubei Province International Science and Technology Cooperation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint blockade (ICB) therapy shows excellent efficacy against malignancies; however, insufficient tumor immunogenicity and the immunosuppressive tumor microenvironment (TME) are considered as the two major stumbling blocks to a broad ICB response. Here, a combinational therapeutic strategy is reported, wherein TME‐reactive oxygen species/pH dual‐responsive signal transducers and activators of transcription 3 inhibitor nanoprodrugs MPNPs are combined with oncolytic herpes simplex virus 1 virotherapy to synergistically ignite pyroptosis for enhancing immunotherapy. MPNPs exhibit a certain level of tumor accumulation, reduce tumor cell stemness, and enhance antitumor immune responses. Furthermore, the simultaneous application of oncolytic viruses (OVs) confers MPNPs with higher tumor penetration capacity and remarkable gasdermin‐E‐mediated pyroptosis, thereby reshaping the TME and transforming “cold” tumors into “hot” ones. This “fire of immunity” strategy successfully activates robust T‐cell‐dependent antitumor responses, potentiating ICB effects against local recurrence and pulmonary metastasis in preclinical “cold” murine triple‐negative breast cancer and syngeneic oral cancer models. Collectively, this work may pave a new way and offer an unprecedented opportunity for the combination of OVs with nanomedicine for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirusesOncolytic VirotherapyNeoplasmsHumansMiceAnimalsPyroptosisImmunotherapyImmunityTumor MicroenvironmentSTAT3 Transcription Factor

Stichwörter der Autor:innen

immunotherapyoncolytic virusesprodrugspyroptosissignal transducers and activators of transcription 3

Substanzen

STAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, P. R. Ch…
  • Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices, Southwest Uni…
  • State Key Laboratory of Virology, Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430079, P. R. China.
  • Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, 430079, P. R. China.

ORCID-Profile: Zhigang Xu, Zhi-Jun Sun

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Hubei Province International Science and Technology Cooperation Project
  • Chongqing Talents of the Exceptional Young Talents Project

Zitieren

APA

Su, W., Qiu, W., Li, S. J., Wang, S., Xie, J., Yang, Q. C., Xu, J., Zhang, J., Xu, Z., & Sun, Z. J. (2023). A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis. Advanced Materials, 35(11). https://doi.org/10.1002/adma.202209379

Vancouver

Su W, Qiu W, Li SJ, Wang S, Xie J, Yang QC, et al. A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis. Advanced Materials. 2023;35(11). doi:10.1002/adma.202209379

BibTeX
@article{Su2023,
  author = {Su, Wen and Qiu, Wei and Li, Shu-Jin and Wang, Shuo and Xie, Jun and Yang, Qi-Chao and Xu, Jiming and Zhang, Junjie and Xu, Zhigang and Sun, Zhi-Jun},
  title = {A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {11},
  doi = {10.1002/adma.202209379}
}
Kostenlos starten →